Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010516
Filing Date
2025-05-15
Accepted
2025-05-15 07:35:46
Documents
78
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 898890
2 EX-31.1 ex31-1.htm EX-31.1 12701
3 EX-31.2 ex31-2.htm EX-31.2 12601
4 EX-32 ex-32.htm EX-32 9808
  Complete submission text file 0001641172-25-010516.txt   6054455

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abeo-20250331.xsd EX-101.SCH 43927
6 XBRL CALCULATION FILE abeo-20250331_cal.xml EX-101.CAL 64804
7 XBRL DEFINITION FILE abeo-20250331_def.xml EX-101.DEF 198630
8 XBRL LABEL FILE abeo-20250331_lab.xml EX-101.LAB 442907
9 XBRL PRESENTATION FILE abeo-20250331_pre.xml EX-101.PRE 364157
80 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 881771
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 25948732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)